CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,754,000 | -16.1% | 701,318 | -0.3% | 0.01% | -60.0% |
| Q2 2021 | $2,091,000 | -15.5% | 703,248 | -0.1% | 0.02% | -16.7% |
| Q1 2021 | $2,475,000 | -26.2% | 703,826 | -0.3% | 0.02% | -35.1% |
| Q4 2020 | $3,352,000 | +9.9% | 705,823 | +12.4% | 0.04% | -9.8% |
| Q3 2020 | $3,051,000 | +144.7% | 627,949 | +63.6% | 0.04% | +95.2% |
| Q2 2020 | $1,247,000 | -60.3% | 383,910 | -37.4% | 0.02% | -67.2% |
| Q1 2020 | $3,139,000 | +16.2% | 613,439 | +3.6% | 0.06% | +52.4% |
| Q4 2019 | $2,701,000 | -20.3% | 592,079 | +6.9% | 0.04% | -20.8% |
| Q3 2019 | $3,388,000 | +20.7% | 553,770 | +20.1% | 0.05% | +26.2% |
| Q2 2019 | $2,806,000 | +15.0% | 460,956 | +4.8% | 0.04% | +10.5% |
| Q1 2019 | $2,441,000 | +23.7% | 439,778 | +26.1% | 0.04% | +11.8% |
| Q4 2018 | $1,973,000 | – | 348,627 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |